| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2008 | EP1937220A2 Ramipril formulation with increased stability |
| 07/02/2008 | EP1937218A2 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
| 07/02/2008 | EP1937217A2 Nanoparticulate tadalafil formulations |
| 07/02/2008 | EP1937216A1 Pharmaceutical composition comprising perindopril or its salts |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1937212A2 Ophthalmic emulsions containing prostaglandins |
| 07/02/2008 | EP1937210A2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 07/02/2008 | EP1937068A2 Muscarinic acetylcholine receptor antagonists |
| 07/02/2008 | EP1937065A2 Novel lysine salts of 4-((phenoxyalkyl) thio)-phenoxyacetic acid derivatives |
| 07/02/2008 | EP1830846A4 Thiazolium compounds and uses thereof |
| 07/02/2008 | EP1830841B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/02/2008 | EP1825861A4 Anti-inflammatory extract and agent and method for the production thereof |
| 07/02/2008 | EP1824488A4 Phycotoxins and uses thereof |
| 07/02/2008 | EP1824473A4 Radioactive chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method |
| 07/02/2008 | EP1802250A4 Methods of treating wounds with gonyautoxins |
| 07/02/2008 | EP1778623B1 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
| 07/02/2008 | EP1729819B1 X-ray visible drug delivery device |
| 07/02/2008 | EP1729773B1 8-hydroxy-5- [(-hydroxy-2- [[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 07/02/2008 | EP1729754B1 Selective norepinephrine reuptake inhibitors for the treatment of hot flashes |
| 07/02/2008 | EP1713447A4 Particulate plant sterol compositions |
| 07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
| 07/02/2008 | EP1691787B1 Method for making pharmaceutical multiparticulates |
| 07/02/2008 | EP1667668B1 Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents |
| 07/02/2008 | EP1660100B1 Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
| 07/02/2008 | EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1646625B1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1635791B1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 07/02/2008 | EP1633745B1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 07/02/2008 | EP1633702B1 Protease inhibitors |
| 07/02/2008 | EP1632233B1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 07/02/2008 | EP1596859B1 Treatment of diseases caused by ljungan virus by using pleconaril |
| 07/02/2008 | EP1593666B1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 07/02/2008 | EP1592451B1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
| 07/02/2008 | EP1572698B1 3-substituted 3,4-dihydro-thieno¬2,3-d pyrimidine-4-one-derivatives, production and use thereof |
| 07/02/2008 | EP1569911B1 Indazole derivatives as crf antagonists |
| 07/02/2008 | EP1567140B1 Synergistic combination comprising roflumilast and (r,r)-formoterol |
| 07/02/2008 | EP1567139B1 New synergistic combination comprising roflumilast and formoterol |
| 07/02/2008 | EP1545492A4 Conjugated linoleic acid powder |
| 07/02/2008 | EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/02/2008 | EP1533313B1 Novel flavone c-glycoside derivatives and composition containing the derivatives |
| 07/02/2008 | EP1509519B1 Crystalline fluoroquinolone arginine salt form |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1495019B1 Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof |
| 07/02/2008 | EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1471916B1 Treatment of rheumatoid arthritis using imatinib |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
| 07/02/2008 | EP1446022B1 Oilseed processing |
| 07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/02/2008 | EP1423385B1 Intermediates for preparing neuraminidase inhibitor conjugates |
| 07/02/2008 | EP1419792B1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 07/02/2008 | EP1333828B1 Prevention of development of dyskinesias |
| 07/02/2008 | EP1328273B1 Felodipine transdermal device and methods |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | EP1282404B1 Method for preparing microparticles having a selected polymer molecular weight |
| 07/02/2008 | EP1265579B1 Container for linezolid intravenous solution |
| 07/02/2008 | EP1252890B1 Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| 07/02/2008 | EP1251818B1 Galenic formulation |
| 07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
| 07/02/2008 | EP1200091B1 Pharmaceutical composition comprising tadalafil |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1165057B1 Endodontic fibers and methods of use therefor |
| 07/02/2008 | EP1128838B1 Extracellular matrix containing gdf-5 for inducing or enhancing chondrogenesis |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | EP0974348B1 Visceral fat lowering agent |
| 07/02/2008 | EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy |
| 07/02/2008 | CN201079620Y Medicament controlled-release catheter |
| 07/02/2008 | CN101213301A Rnai for control of insects and arachnids |
| 07/02/2008 | CN101213300A Oligonucleotides for RNA interference and biological applications thereof |
| 07/02/2008 | CN101213292A Methods and compositions for regulating biofilm development |
| 07/02/2008 | CN101213281A 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament |
| 07/02/2008 | CN101213200A Platinum complexes with mononitrile-containing ligands |
| 07/02/2008 | CN101213198A 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors |
| 07/02/2008 | CN101213197A Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists |
| 07/02/2008 | CN101213196A Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 07/02/2008 | CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 07/02/2008 | CN101213194A Indazoles useful in treating cardiovascular diseases |
| 07/02/2008 | CN101213193A Mono-lysine salts of azole compounds |
| 07/02/2008 | CN101213192A Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 07/02/2008 | CN101213190A Compounds and compositions as TPO mimetics |
| 07/02/2008 | CN101213188A Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation |
| 07/02/2008 | CN101213187A Isoquinoline derivatives as inhibitors of RHO-kinase |
| 07/02/2008 | CN101213186A Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 07/02/2008 | CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 07/02/2008 | CN101213184A Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 07/02/2008 | CN101213183A Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
| 07/02/2008 | CN101213182A Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators |
| 07/02/2008 | CN101213179A 2,4-diamino-pyrimidines used as Aurora inhibitors |
| 07/02/2008 | CN101213178A Benzenoid ansamycin derivative |
| 07/02/2008 | CN101213175A Bicyclic derivatives as p38 kinase inhibitors |
| 07/02/2008 | CN101213174A Oxindole compounds and their uses as therapeutic agents |
| 07/02/2008 | CN101213171A New crystalline atorvastatin hemicalcium salt polymorph form |
| 07/02/2008 | CN101212987A Self-sterilizing products |
| 07/02/2008 | CN101212986A Stable emulsion composition |
| 07/02/2008 | CN101212981A Pharmaceutical formulations for minimizing drug-drug interactions |
| 07/02/2008 | CN101212980A Use of macrolides for treating intestinal inflammation |
| 07/02/2008 | CN101212979A 内脏脂肪蓄积抑制剂 The visceral fat accumulation inhibitor |